Hold with defensive architecture: participate in structural upcycle via existing exposure, add only on trend-confirmed breakout, hedge macro tail risk
Hold reflects calibrated uncertainty about next quarter while participating in the structural upcycle — not no opinion. The 9/18 structural-bid lesson forecloses Underweight at +15% above 200 SMA with ROE 65.1%, net cash $1.85B, sold-out backlog, and intact rising 200 SMA. The 10/02 lesson forecloses aggressive Buy at $320 with short-term momentum exhaustion (10 EMA rollover 4 sessions, 65% MACD compression in 6 sessions) into 1.85-beta volatility and 96%-no-cut macro multiple compression risk. Risk/reward is 0.88:1 raw (upside $380 PT +18.75% vs downside $252 stop -21.25%) but adjusted for ~50% structural-bid probability, put hedge transfer, and Q3 FCF recovery potential, risk-adjusted asymmetry is 1.3-1.5:1 to upside — positive but not aggressive, textbook Hold.
| Position | Action |
|---|---|
| Current position ≤1.5x benchmark weight | Maintain existing exposure at 1.5x benchmark with 1.85 beta |
| Close below $310 (50 SMA) with volume | Execute 25% trim — captures structural break that admits bull case wrong |
| Confirmed beat-and-raise outcome | Preserve $360 trim trigger only for confirmed break-and-raise |
| 4-5% of position size in 3-6 month $300 LRCX puts | Mandatory macro hedge architecture (dispositive per 10/07 lesson) |
The Q2 2026 print confirms a cyclical inflection is underway with accelerating revenue, margin expansion, and receivables surging +29% QoQ as a leading indicator; the risk/reward at $320.59 with a 27x forward P/E in line with WFE peers is decisively favorable for a BUY.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | $278.00 | bullish |
| 50 SMA | $310.02 | bullish |
| 10 EMA | $326.63 | bearish |
| MACD Line | +8.15 | bullish |
| MACD Signal | +5.87 | bullish |
| MACD Histogram | +2.28 (compressed from +6.44) | neutral |
| RSI (14) | 52.14 | neutral |
| Bollinger Upper Band | $360.44 | neutral |
| Bollinger Mid Band (20 SMA) | $309.70 | bullish |
| Bollinger Lower Band | $258.96 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close > $326.63 (10 EMA) with MACD histogram re-expanding above +3
Then: Add confirmation tranche — respects trend without requiring stock to come to us
↩ rebuts: “Bear's 'wait for trigger' approach misses that this is the trigger”
EV: +22.4% · concedes: Forward P/E of 27x is not cheap on an absolute basis, though it is in line with WFE peers (ASML 30-35x, AMAT 25-28x, KLAC 28-30x); HBM cycle and recovery may already be partially priced in; High beta of 1.85 increases volatility exposure; Bear case (15% probability) includes downside to $259-310 on a Q3 miss; MACD histogram compression from +6.44 to +2.28 represents real momentum cooling, though from a recovering level not weakness
LRCX's +22.4% expected return is "structurally rigged" — the Q2 "inflection" is a mechanical rebound from a depressed base, not a structural break, and realistic probability weighting with proper downside scenarios yields only +1.2% expected return versus the bull's +22.4%.
EV: +1.2% (realistic re-run) or +0.65% (alternative calculation) · concedes: The moat (GAA etch leadership, HBM tool share) is real; Q2 2026 revenue acceleration is real data; Pullback to $285-310 would improve risk/reward; Post-Q3 beat-and-raise could change thesis
→ vs conservative: Base-rate stress testing claim is risk aversion masquerading as analysis; conservative cherry-picks bear base rate while ignoring historical bull base rate for identical inflection prints across Lam, Applied Materials, ASML, and KLA
→ vs conservative: DSO deterioration argument is analytically lazy; treating receivables growing faster than revenue as red flag ignores that in wafer fab equipment business this is leading indicator of accelerating shipments, not collection problem
→ vs conservative: Scaling-in plan requiring 6% pullback to $300 with RSI>40 before adding 25% target is defeatist; waiting for gifts that markets may not give rather than acting on current favorable setup at $320
→ vs neutral: 10 EMA rollover ($327 to $326) and MACD histogram compression are mechanical readings that miss the structural context — stock above rising 50 SMA ($310) and well above rising 200 SMA ($278 from $201 four months ago); short-term cooling within medium and long-term uptrends is bull flag, not breakdown
→ vs neutral: ATR compression from $28 to $13.74 is not a 'be careful' signal but rather volatility compression that historically resolves in direction of prevailing uptrend
→ vs neutral: Absence of LRCX-specific news is not neutral signal; for $400B market cap semi-cap name, quiet news with loud Q2 fundamentals means no negative catalyst on tape and path of least resistance is higher
→ vs neutral: Macro caution (96% no-cut odds, soft chip tape, gold bid) misses that this regime is fully priced in; asymmetric risk is cycle inflecting faster than macro consensus expects with earnings revisions moving upward into year-end
| ATR (14) |
| $13.74 |
| neutral |
| VWMA | $320.42 | bullish |
| Volume (Oct-8) | 8.96M | neutral |
Support: 309.7 · 310.02 · 278 · 258.96 | Resistance: 326.63 · 333.89 · 347.49 · 360.44
LRCX exhibits a classic post-rally consolidation pattern with conflicting signals across timeframes: long-term trend remains intact (200 SMA rising at $278.00, price 13% above), medium-term is positive but decelerating (50 SMA at $310.02 flattening), and short-term momentum is bearish (price below 10 EMA at $326.63 with MACD histogram compressing). RSI at 52.14 sits in neutral territory, while ATR has compressed to $13.74 from ~$28 in early July, indicating lower volatility. Key support lies at the $310 confluence zone (50 SMA + Bollinger mid), with resistance at the 10 EMA ($326.63); a decisive break above or below these levels will determine the next directional move.
Market Cap
$401.19B
TTM P/E
55.66x
Forward P/E
27.25x
PEG Ratio
1.55
Price/Book
32.17x
EPS (TTM)
$5.76
Forward EPS
$11.76
Dividend Yield
0.40%
Beta
1.854
52-Week Range
$131.02 – $438.50
50-Day MA
$308.91
200-Day MA
$277.70
Profit Margin
31.27%
Operating Margin
37.39%
Gross Margin (TTM)
~50.5%
Gross Margin (Q2 2026)
51.8%
EBITDA Margin
37.2%
ROE
65.07%
ROA
22.84%
TTM Revenue
$23.23B
Q2 2026 Revenue
$6,722M
Q2 2026 EPS
$1.81
Q2 2026 Gross Profit
$3,479M
Q2 2026 Operating Income
$2,513M
Q2 2026 Net Income
$2,277M
TTM Free Cash Flow
$3.09B
Q2 2026 Free Cash Flow
$1,268M
Q2 2026 Operating Cash Flow
$1,457M
Q2 2026 Capex
$189M
Q2 2026 R&D
$642.9M
Q2 2026 Buybacks
$247M
Q2 2026 Dividends
$325M
Total Assets
$23.53B
Total Debt
$3.73B
Net Cash Position
$1.85B
Cash & Equivalents
$5.58B
Stockholders' Equity
$12.47B
Debt/Equity
~0.30x
Working Capital
$9.67B
Current Ratio
2.63x
Inventory
$4.28B
Receivables
$5.34B
Treasury Stock
$31.6B
Strengths
Concerns
Lam Research is at a clear cyclical inflection point with Q2 2026 results validating a multi-quarter WFE upcycle thesis. Revenue and earnings are accelerating (Q2 2026 revenue $6.72B, EPS $1.81), gross and operating margins are expanding (51.8% and 37.4% respectively), the balance sheet is strong with a net cash position of $1.85B, and capital returns remain aggressive at $500M-$1.5B+ per quarter. However, valuation (Forward P/E ~27x, P/B 32x) already prices in substantial recovery, and the stock trades closer to its 52-week high than its low, creating limited downside cushion given the elevated Beta of 1.85. Cyclical exposure and geopolitical/export control risks remain structural overhangs.
Macro: Restrictive-but-stable macro regime: Polymarket prices 96% probability of ZERO Fed rate cuts in 2026 (~$8.8M volume), with only 6% odds of US recession by end-2026 (down 2pp on the week). Long rates pinned at highest in nearly three years (mortgage rates). Oil fell to $103 on Iran de-escalation. Gold at $4,131.80 (+0.44%) with Bitcoin below $83,000 indicating cross-asset risk-off. No FRED macro series available this session. The regime implies higher-for-longer rates without imminent recession—pressuring WFE capex digestion and long-duration growth multiples, but not in acute risk-off.